We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Ethnic comparison of pharmacokinetics of F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects.
- Authors
Senda, Michio; Sasaki, Masahiro; Yamane, Tomohiko; Shimizu, Keiji; Patt, Marianne; Barthel, Henryk; Sattler, Bernhard; Nagasawa, Toshiki; Schultze-Mosgau, Marcus; Aitoku, Yasuko; Dinkelborg, Ludger; Sabri, Osama
- Abstract
Purpose: F-Florbetaben is a positron emission tomography (PET) tracer indicated for imaging cerebral beta-amyloid deposition in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline. The present study examined ethnic comparability of the plasma pharmacokinetics, which is the input to the brain, between Caucasian and Japanese subjects. Methods: Two identical phase I trials were performed in 18 German and 18 Japanese healthy volunteers to evaluate the plasma pharmacokinetics of a single dose of 300 MBq F-florbetaben, either of low (≤5 μg, LD) or high (50-55 μg, HD) mass dose. Pharmacokinetic parameters were evaluated based on the total F radioactivity measurements in plasma followed by metabolite analysis using radio-HPLC. Results: The pharmacokinetics of F-florbetaben was characterized by a rapid elimination from plasma. The dose-normalized areas under the curve of F-florbetaben in plasma as an indicator of the input to the brain were comparable between Germans (LD: 0.38 min/l, HD: 0.55 min/l) and Japanese (LD: 0.35 min/l, HD: 0.45 min/l) suggesting ethnic similarity, and the mass dose effect was minimal. A polar metabolite fraction was the main radiolabelled degradation product in plasma and was also similar between the doses and the ethnic groups. Conclusion: Absence of a difference in the pharmacokinetics of F-florbetaben in Germans and Japanese has warranted further global development of the PET imaging agent.
- Subjects
POSITRON emission tomography; PHARMACOKINETICS; ALZHEIMER'S disease diagnosis; AMYLOID beta-protein; CAUCASIAN race; JAPANESE people; HEALTH
- Publication
European Journal of Nuclear Medicine & Molecular Imaging, 2015, Vol 42, Issue 1, p89
- ISSN
1619-7070
- Publication type
Article
- DOI
10.1007/s00259-014-2890-8